ArticleJournal for immunotherapy of cancer2023

Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors.

No numbers read from the abstract.

Not cited yet